Dear Sir, Submitting the Dislosure under Regulatiom 29(2) under SEBI (SAST) Regulation 2011. Sumitted by Vijaya Mani the Promoter and Director of the Company anaingt sell of her Equity ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.3 pts more than Nifty Microcap 250 and 4.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vijaya Mani, Promoter and Director of Colinz Laboratories Ltd, sold 3,78,000 equity shares in an off-market transaction on May 21, 2026. Before the sale, she held 12,48,500 shares representing 49.56% of the company's share capital. After the sale, her holding reduced to 8,70,500 shares representing 34.56%. The total share capital of the company remained unchanged at Rs. 2,51,91,000. The transaction was completed on May 23, 2026.
This is a significant negative signal for shareholders as the promoter has reduced her stake by nearly 15 percentage points, crossing below the 50% threshold. This indicates reduced promoter commitment and may signal a lack of confidence in the company's prospects.